Chemoinformaics analysis of RUSCODIBENZOFURAN
| Molecular Weight | 254.285 | nRot | 1 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 16 |
| Exact Molecular Weight | 254.094 | nRing | 3 |
| Solubility: LogS | -4.69 | nHRing | 1 |
| Solubility: LogP | 4.595 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 15 |
| nHA | 3 | APOL | 38.4611 |
| nHD | 1 | BPOL | 16.6489 |
| QED | 0.665 |
| Synth | 2.372 |
| Natural Product Likeliness | 0.543 |
| NR-PPAR-gamma | 0.772 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.463 |
| HIA | 0.007 |
| CACO-2 | -4.832 |
| MDCK | 0.0000199 |
| BBB | 0.028 |
| PPB | 0.953607 |
| VDSS | 0.512 |
| FU | 0.0408063 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.923 |
| CYP2c19-inh | 0.882 |
| CYP2c19-sub | 0.099 |
| CYP2c9-inh | 0.752 |
| CYP2c9-sub | 0.887 |
| CYP2d6-inh | 0.657 |
| CYP2d6-sub | 0.886 |
| CYP3a4-inh | 0.428 |
| CYP3a4-sub | 0.255 |
| CL | 6.253 |
| T12 | 0.352 |
| hERG | 0.008 |
| Ames | 0.583 |
| ROA | 0.136 |
| SkinSen | 0.666 |
| Carcinogencity | 0.901 |
| EI | 0.888 |
| Respiratory | 0.499 |
| NR-Aromatase | 0.773 |
| Antiviral | Yes |
| Prediction | 0.670142 |